Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia

about

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia

Item

http://www.wikidata.org/entity/Q37055381

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia

@en

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia.

@nl

type

Item

label

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia

@en

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia.

@nl

prefLabel

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia

@en

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia.

@nl

P1476

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia

@en

P2093

Federica Sorà

http://www.w3.org/2001/XMLSchema#string

Francesco Autore

http://www.w3.org/2001/XMLSchema#string

Luca Laurenti

http://www.w3.org/2001/XMLSchema#string

Patrizia Chiusolo

http://www.w3.org/2001/XMLSchema#string

Simona Sica

http://www.w3.org/2001/XMLSchema#string

P2860

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Recurrent arterial and venous thromboemboli as initial presentation of acute promyelocytic leukemia.

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.

Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

The coagulopathy of acute promyelocytic leukaemia revisited.

The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia.

Bleeding and thrombosis in acute promyelocytic leukemia.

P304

e2016027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4084/MJHID.2016.027

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sabrina Giammarco

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27413520

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

4928521

http://www.w3.org/2001/XMLSchema#string